Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... During the quarter Alcon received additional country approvals of Vigamox® ophthalmic solution and the drug is now approved in a majority of European Union countries. The ...
2009 NOV 9 ... purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today ...
2009 NOV 9 ... through 27 at the Moscone Center, San Francisco, CA. As the largest, most comprehensive ophthalmic education conference in the world, it offers United States and international Eye M.D.s ... of impairment that makes daily tasks and economic success difficult. Seeking a low-cost solution, Thomas S. Shane, MD, Bascom Palmer Eye Institute, University of Miami, developed a ...
2009 NOV 2 ... No one had the combination of features, flexibility, and understanding of the ophthalmic surgery segment that MedInformatix offered," said Sam Byers, practice administrator for ... Byers, practice administrator for Talley Eye Care. "We knew MedInformatix was the right solution in 1999, and it has been ever since." Talley Eye Care is an asset to the ...
2009 NOV 2 ... advances of our wound care technology can be applied to the treatment of DES and other ophthalmic diseases. Our point-of-care indicator system has the potential to provide earlier and ... can lead to additional tissue damage and potential blindness. A solution to proper discernment between inflammatory and non-inflammatory conditions would result ...
2009 NOV 16 ... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration (FDA) for Sun ...
2009 NOV 2 ... After surgery, the rabbits were divided into 3 treatment groups: diclofenac sodium ophthalmic solution, bromfenac sodium ophthalmic solution, and ...
2009 NOV 23 ... objectives." Recent Accomplishments and Events Prescriptions of AzaSite (azithromycin ophthalmic solution) 1%, InSite Vision's product for the treatment of bacterial conjunctivitis, increased ...
2009 OCT 19 ... products for the treatment of bacterial eye infections, AzaSite® (azithromycin ophthalmic solution) 1% and Besivance™ (besifloxacin ophthalmic suspension) 0.6%. AzaSite is approved ...
2009 NOV 16 ... (Trial 03-113) with PROLACRIA, the proposed U.S. tradename for diquafosol tetrasodium ophthalmic solution 2%, for the treatment of dry eye disease. This is a six-week trial comparing PROLACRIA ...
2009 NOV 16 ... quarter of 2008, reflecting an increase of 26%. Revenue from AZASITE® (azithromycin ophthalmic solution) 1% totaled $9.0 million in the third quarter of 2009, an increase of 92% compared to ...
2009 NOV 2 ... compounds in Inspire's clinical pipeline are Prolacria™ (diquafosol tetrasodium ophthalmic solution) 2% for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase 3 ...
2009 NOV 23 ... announced additional results from the Company's Bepreve™ (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies. These results were presented in poster sessions at the ...
2009 NOV 2 ... poster presentations of results from the Company's Bepreve™ (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated ...
2009 NOV 16 ... 2009 is $1.2 million associated with the launch of Bepreve™ (bepotastine besilate ophthalmic solution) 1.5% and $2.9 million of previously deferred revenue associated with the termination of ...
2009 OCT 19 ... a biological effect on blood flow in the back of the retina. Mystic's VersiDoser™ ophthalmic delivery system was used by trial participants to self-administer MC-1101 to the front ... that has the potential to provide a simpler, safer and ultimately cost effective solution to the millions of people suffering from this disease." Ralston added that, "Mystic's ...
2009 NOV 3 ... Presbia, a company focused on surgical solutions for presbyopia, announced that ophthalmic surgeons Dr. Michael Gordon and Dr. Robert Maloney have agreed to join to its Medical ... philosophy, politics and economics. Flexivue™ Micro-Lens Presbia's revolutionary solution to presbyopia involves the placement of the Flexivue micro-lens, which is just three ...
2009 NOV 23 ... by Schirmer I tear test. Fourteen adult horses received one drop of 1% tropicamide ophthalmic solution in one eye and the opposite eye served as the control.""The tear ...
2009 NOV 17 ... care as well as adult strabismus, and they are the major referral center for pediatric ophthalmic disorders in the area. Their physicians are part of the faculty at both Robert Wood ... high-performance practices," says Evan Steele, CEO of SRSsoft. "Our easily adoptable solution will allow University Children's Eye Center to see an increase in workflow efficiency ...
